| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 04/22/2010 | US20100098713 Drug screening; assay for aldehyde dehydrogenase activity; cancer |
| 04/22/2010 | US20100098711 Antagonist antibodies against ephb3 |
| 04/22/2010 | US20100098709 Antibodies Specific For The Complex Of Interleukin-6 And The Interleukin-6 Receptor |
| 04/22/2010 | US20100098695 Biomarker specific to brain/nerve or specific to neuronal differentiation |
| 04/22/2010 | US20100098693 Compositions and methods for blood-brain barrier delivery of organophosphatases |
| 04/22/2010 | US20100098687 Compositions and methods for treating thymic stromal lymphopoietin (tslp)-mediated conditions |
| 04/22/2010 | US20100098682 Effect of Bri Proteins on Ass Production |
| 04/22/2010 | US20100098680 Anti-pathogen treatments |
| 04/22/2010 | US20100098676 Synergistic anti-inflammatory and antioxidant dietary supplement compositions |
| 04/22/2010 | US20100098659 Compositions and methods for treating matrix metalloproteinase 9 (mmp9)-mediated conditions |
| 04/22/2010 | US20100098634 Imaging Agents Useful for Identifying AD Pathology |
| 04/22/2010 | US20100098629 Novel Amides Acting on the Adenosine Receptors |
| 04/22/2010 | CA2741060A1 Compositions and methods for treatment of renin-angiotensin aldosterone system (raas)-related disorders |
| 04/22/2010 | CA2741029A1 Spiro-oxindole compounds and their use as therapeutic agents |
| 04/22/2010 | CA2741024A1 Spiro-oxindole compounds and their use as therapeutic agents |
| 04/22/2010 | CA2740969A1 Novel thiophene compounds for use in theraphy |
| 04/22/2010 | CA2740696A1 Heterocyclic benzimidazoles as trpm8 modulators |
| 04/22/2010 | CA2740610A1 Methods and compositions for improving cognitive function |
| 04/22/2010 | CA2740525A1 Heterocyclyl and cycloalkyl substituted thieno[2,3-d]pyrimidine and their use as adenosine a2a receptor antagonists |
| 04/22/2010 | CA2740424A1 Amines and sulfoxides of thieno[2,3-d]pyrimidine and their use as adenosine a2a receptor antagonists |
| 04/22/2010 | CA2740413A1 Heteroaryl substituted thieno[2,3-d]pyrimidine and their use as adenosine a2a receptor antagonists |
| 04/22/2010 | CA2740412A1 Phenyl substituted thieno[2,3-d]pyrimidines and their use as adenosin a2a receptor antagonists |
| 04/22/2010 | CA2740411A1 Heteroaryl and phenyl substituted thieno[2,3-d]pyrimidines and their use as adenosine a2a receptor antagonists |
| 04/22/2010 | CA2740410A1 Phenyl and heteroaryl substituted thieno[2,3-d] pyrimidines and their use as adenosine a2a receptor antagonists |
| 04/22/2010 | CA2740408A1 Amides of thieno[2,3-d]pyrimidine and their use as adenosine a2a receptor antagonists |
| 04/22/2010 | CA2740406A1 Methylene amines of thieno[2,3-d]pyrimidine and their use as adenosine a2a receptor antagonists |
| 04/22/2010 | CA2739488A1 Fused heteroaryl diamide compounds useful as mmp-13 inhibitors |
| 04/22/2010 | CA2738849A1 Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors |
| 04/22/2010 | CA2738806A1 Nicotinic acetylcholine receptor ligands and the uses thereof |
| 04/22/2010 | CA2737855A1 Di-vanilloyl and tri-vanilloyl derivatives for use in anti-cancer therapy |
| 04/22/2010 | CA2737754A1 Co-crystals of tramadol and nsaids |
| 04/22/2010 | CA2737307A1 Multi portion intra-oral dosage form and use thereof |
| 04/22/2010 | CA2736409A1 Benzoquinoline inhibitors of vesicular monoamine transporter 2 |
| 04/22/2010 | CA2708674A1 Compositions for the prevention and treatment of neuroinjury and methods of use thereof |
| 04/21/2010 | EP2177619A1 HSV strains for the oncolytic treatment of cancer |
| 04/21/2010 | EP2177536A1 Antibodies against amyloid-beta peptide |
| 04/21/2010 | EP2177529A1 Novel -secretase inhibitor |
| 04/21/2010 | EP2177520A1 1,5-Di(aryl or heteroaryl)-3-halo-2(1H)-pyridones as intermediates for the preparation of AMPA receptor inhibitors |
| 04/21/2010 | EP2177513A1 Phenylacetic acid compound |
| 04/21/2010 | EP2177505A1 Bicyclic acylguanidine derivative |
| 04/21/2010 | EP2177231A2 Use of goat serum for veterinary treatment |
| 04/21/2010 | EP2177228A1 DNA vaccination for treatment of autoimmune disease |
| 04/21/2010 | EP2177218A1 Regenerative therapy |
| 04/21/2010 | EP2177217A1 Composition comprising rotigotine, its use and transdermal patch comprising the composition |
| 04/21/2010 | EP2177215A1 Co-crystals of tramadol and NSAIDs |
| 04/21/2010 | EP2176258A1 Piperidine derivatives useful as orexin receptor antagonists |
| 04/21/2010 | EP2176252A1 2, 3-dihydrobenzo[1, 4]dioxin-2-ylmethyl derivatives as alpha2c antagonists for use in the treatment of peripheric and central nervous systeme diseases |
| 04/21/2010 | EP2176251A2 5-pyridinone substituted indazoles |
| 04/21/2010 | EP2176250A1 Substituted heteroarylpiperidine derivatives as melanocortin-4 receptor modulators |
| 04/21/2010 | EP2176233A1 Gamma secretase modulators |
| 04/21/2010 | EP2176217A1 Amino acid derivatives |
| 04/21/2010 | EP2176208A1 Prodrugs of cannabidiol, compositions comprising prodrugs of cannabidiol and methods of using the same |
| 04/21/2010 | EP2175932A1 New neuronal viability factor and use thereof |
| 04/21/2010 | EP2175886A1 Combination methods and compositions for treatment of neuropathic pain |
| 04/21/2010 | EP2175879A1 Treatment of prion protein related diseases |
| 04/21/2010 | EP2175868A1 Methods and compositions for treating neural degeneration |
| 04/21/2010 | EP2175850A1 Methods for treating anxiety |
| 04/21/2010 | EP2175848A1 Therapeutic uses of cannabigerol |
| 04/21/2010 | EP2175844A1 Substituted fluoroethyl ureas as alpha 2 adrenergic agents |
| 04/21/2010 | EP1910296B1 4-aryloxy quinoline derivatives as 5-ht6 modulators |
| 04/21/2010 | EP1708790B1 Use of pipamperone and a d2-receptor antagonist or a serotonin/dopamin antagonist for the treatment of psychotic disorders |
| 04/21/2010 | EP1620082B1 Medical use of inhibitors of glutaminyl and glutamate cyclases for treating alzheimer's disease and down syndrome |
| 04/21/2010 | EP1479670B1 Novel fused ring indazole compounds |
| 04/21/2010 | EP1392256B1 Improved transdermal therapeutic system for the treatment of parkinson's disease |
| 04/21/2010 | EP1387685B1 Analgesic composition comprising an opioid and a sodium channel blocker |
| 04/21/2010 | EP1272175B1 N,n'-diaryl guanidines as il-8 receptor antagonists |
| 04/21/2010 | EP1250328B2 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
| 04/21/2010 | CN1931269B Rutin containing medicine composition |
| 04/21/2010 | CN1923820B Novel carboxylic acid derivatives, their preparation and use |
| 04/21/2010 | CN1895340B Sobering-up composition |
| 04/21/2010 | CN1864704B Herbal composition for treatment of arthritic disorders, skin inflammatory disorders and pain |
| 04/21/2010 | CN1854134B Piperazine compounds, their preparation method and pharmaceutical composition containing same |
| 04/21/2010 | CN1740169B Arylmethylamine derivatives for use as tryptase inhibitors |
| 04/21/2010 | CN1689628B Medical purpose of creat extract |
| 04/21/2010 | CN101696208A Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with a cyclic amino group as crf antagonists |
| 04/21/2010 | CN101696205A 3-(substituted xylylenimine-2-yl)-2,6-dioxopiperidine polymorph and pharmaceutical composition |
| 04/21/2010 | CN101695566A Chinese medicament for treating cephalagra |
| 04/21/2010 | CN101695565A Traditional Chinese medicine for drug rehabilitation and detoxification |
| 04/21/2010 | CN101695526A Composition Chinese medicament for treating salivation |
| 04/21/2010 | CN101695522A Chinese medicinal composition for treating insomnia |
| 04/21/2010 | CN101695518A Method for extracting total alkaloid of common fibraurea stems, separate fibriuretinin and jatrorrhizine |
| 04/21/2010 | CN101695505A Preparation method of enzyme hydrolysis pearl powder |
| 04/21/2010 | CN101695504A Preparation method of nanometer pearl powder |
| 04/21/2010 | CN101695500A Application of potassium chloride (KCl) in pharmacy |
| 04/21/2010 | CN101695374A Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product |
| 04/21/2010 | CN101028451B Chinese medicine for treating tic douloureux |
| 04/21/2010 | CN101011521B Chinese patent drug for nourishing liver and kidney, tranquilizing the mind and developing intelligence and its preparation method |
| 04/20/2010 | US7700837 Transformed plant cell expressing tandem repeats of beta-amyloid gene and plant produced by the same |
| 04/20/2010 | US7700719 Mutant protofibril for active immunisation; synuclein genes, proteins; point mutations; Parkinson's disease; dementia; host cells |
| 04/20/2010 | US7700657 Vitamin D analogs |
| 04/20/2010 | US7700635 Neuroprotectants; treatment of neuropathies resulting from chemtherapeutic agents used in the treatment of HIV and proliferative disease such as cancer and treatment of inflammatory diseases; neurodegenerative diseases; enzyme inhibitorsfor seine/threonine kinases, phosphatases; Alzheimer's |
| 04/20/2010 | US7700631 Use of pyridine N-oxide analogs at doses which do not induce emesis |
| 04/20/2010 | US7700630 3-Quinolin-2-ylmethylene-3,4,5,6-terahydro[2,3']bipyridinyl; for therapy and prophylaxis of psychotic diseases, neurodegenerative diseases involving a dysfunction of the cholinergic system |
| 04/20/2010 | US7700619 Monohydrates; monoamine neurotransmitter re-uptake inhibitors; central nervous system; nervous system disorders; stability; hydrophobic;bioavailability; handling; melting points; reproduction; crystal structure |
| 04/20/2010 | US7700604 (5S)-5-methyl-5-({[6-[2-(trifluoromethyl)pyrimidin-5-yl]-3,4-dihydroisoquinolin-2(1H)-yl]sulfonyl}methyl)imidazolidine-2,4-dione; asthma, rhinitis, chronic obstructive pulmonary diseases (COPD), arthritis (such as rheumatoid arthritis and osteoarthritis), atherosclerosis, cancer |
| 04/20/2010 | US7700598 Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions |
| 04/20/2010 | US7700595 such as 3-benzyl-4-phenyl-8-(trifluoromethyl)cinnoline; modulators of Liver X receptors (LXRs) |
| 04/20/2010 | US7700587 Haloperidol analogs |
| 04/20/2010 | US7700586 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders |
| 04/20/2010 | US7700585 Derivatives of N-[phenyl(pyrrolidine-2-YL)methyl]benzamide and N-[(azepan-2-YL) phenylmethyl]benzamide, preparation method thereof and application of same in therapeutics |